REFERENCES
- Zeng YT, Huang SZ, Xu L, Hb Wuming or α2 11(A9)LYS→GLN β2. Hemoglobin. 1981;5(7–8):679–687.
- Kemper AR, Knapp AA, Metterville DR, Comeau AM, Green NS, Perrin JM. Weighing the evidence for newborn screening for Hemoglobin H disease. J Pediatr. 2011;158(5):780–783.
- Kyriacou K, Kyrri A, Kalogirou E, Hb Bart’s levels in cord blood and α-thalassemia mutations in Cyprus. Hemoglobin 2000;24(3):171–180.
- Rugless MJ, Fisher CA, Stephens AD, Amos RJ, Mohammed T, Old JM. Hb Bart’s in cord blood: an accurate indicator of α-thalassemia. Hemoglobin. 2006;30(1):57–62.
- Lin TM, Eng HL, Kuo PL, Wu HL. Neonatal screening for α -thalassemia in southern Taiwan. J Formos Med Assoc. 1992;91(12):1213–1215.
- Munkongdee T, Pichanun D, Butthep P, Quantitative analysis of Hb Bart’s in cord blood by capillary electrophoresis system. Ann Hematol. 2011;90(7):741–746.